ArticleTheranostics2020

Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy.

Cheng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.